How to risk stratify new‐onset atrial fibrillation in patients with hypertension and diabetes mellitus

How to risk stratify new‐onset atrial fibrillation in patients with hypertension and diabetes mellitus

Bibliographic Details
Main Authors:	Naoya Kataoka, Teruhiko Imamura
Format:	Article
Language:	English
Published:	Wiley 2024-02-01
Series:	Journal of Arrhythmia
Online Access:	https://doi.org/10.1002/joa3.12963

Similar Items

How to prevent recurrence of atrial fibrillation after catheter ablation
by: Naoya Kataoka, et al.
Published: (2024-02-01)

How to predict postoperative atrial fibrillation after cardiac surgery
by: Naoya Kataoka, et al.
Published: (2024-02-01)

How to demonstrate factors associated with peri‐esophageal vagal nerve injury during catheter ablation for atrial fibrillation
by: Naoya Kataoka, et al.
Published: (2024-06-01)

Clinical implication of smartphone‐based atrial fibrillation detection system
by: Naoya Kataoka, et al.
Published: (2024-12-01)

Clinical implication of hyperuricemia on the recurrence of atrial fibrillation after catheter ablation
by: Naoya Kataoka, et al.
Published: (2024-06-01)

Clinical implication of ANTWERP score in patients receiving catheter ablation for atrial fibrillation
by: Naoya Kataoka, et al.
Published: (2025-02-01)

Detailed causality between high‐sensitivity C‐reactive protein and recurrence of atrial fibrillation after catheter ablation
by: Naoya Kataoka, et al.
Published: (2023-12-01)

Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure
by: Takahisa Koi, et al.
Published: (2021-05-01)

Urinary isoxanthopterin as a novel predictor following catheter ablation for atrial fibrillation
by: Takahisa Koi, et al.
Published: (2023-04-01)

Adverse Events Requiring Hospitalization Following Catheter Ablation for Atrial Fibrillation in Heart Failure with versus without Systolic Dysfunction
by: Naoya Kataoka, et al.
Published: (2024-01-01)

How to assess cryoballoon ablation‐related adverse events
by: Naoya Kataoka, et al.
Published: (2023-12-01)

How to predict the existence of epicardial conduction in the right pulmonary vein carina
by: Naoya Kataoka, et al.
Published: (2024-02-01)

How to demonstrate drug‐induced Type 1 Brugada pattern electrocardiogram
by: Naoya Kataoka, et al.
Published: (2024-12-01)

Effect of Atrial Fibrillation on the Risk of New-onset Myocardial Infarction in Hypertensive Population
by: YUE Bocheng, HOU Qiqi, HAN Quanle, YANG Bo, WU Zheng, WU Jianmei, CHEN Shuohua, WU Shouling, LI Kangbo
Published: (2023-05-01)

How to demonstrate clinical implication of 7‐day continuous electrocardiographic patch monitoring
by: Naoya Kataoka, et al.
Published: (2023-10-01)

Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups
by: Eun Ju Cho, et al.
Published: (2024-09-01)

How to consider the indication of leadless pacemaker versus conventional transvenous pacemaker following their comparison in cost‐effectiveness
by: Naoya Kataoka, et al.
Published: (2025-02-01)

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients
by: Francesca Coccina, et al.
Published: (2021-01-01)

Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study
by: JungMin Choi, et al.
Published: (2023-01-01)

How to Improve Very Low Adherence to Anticoagulation Therapy in Elderly Patients with Non-Valvular Atrial Fibrillation [Letter]
by: Kataoka N, et al.
Published: (2024-01-01)

Atrial fibrillation does not equal atrial fibrillation: The important prognostic implications of new-onset atrial fibrillation
by: Andreas Goette, et al.
Published: (2025-02-01)

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation
by: Ziberna, K, et al.
Published: (2016)

Role of diabetes mellitus in atrial fibrillation and potential new treatments
by: Ziberna, K
Published: (2020)

Does Atrial Fibrillation Increase the Risk of New Onset Myocardial Infarction?
by: Yujing HAO, Jie YU, Quanle HAN, Ruiying MAO, Jing YU, Lihua SONG, Shouling WU
Published: (2022-06-01)

Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-03-01)

Advantage of extracorporeal membrane oxygenation support during catheter ablation for malignant ventricular tachycardia
by: Naoya Kataoka, et al.
Published: (2024-02-01)

Clinical advantage of zero to minimal fluoroscopy for cardiac electronic device implantable
by: Naoya Kataoka, et al.
Published: (2024-02-01)

Clinical implication of R wave in aVR during ventricular tachycardia or premature ventricular contraction
by: Naoya Kataoka, et al.
Published: (2024-12-01)

The causality between premature ventricular contraction and heart failure
by: Naoya Kataoka, et al.
Published: (2025-02-01)

Clinical implication of ivabradine‐incorporated medical therapy for junctional ectopic tachycardia following pediatric cardiac surgery
by: Naoya Kataoka, et al.
Published: (2025-02-01)

Clinical Implication of Ivabradine in Patients Receiving Off-pump Coronary Artery Bypass Surgery
by: Naoya Kataoka, et al.
Published: (2024-04-01)

Clinical advantage of multidetector computed tomography‐guided trans‐septal puncture
by: Naoya Kataoka, et al.
Published: (2024-04-01)

Factors associated with procedure‐related cardiac tamponade
by: Naoya Kataoka, et al.
Published: (2023-12-01)

Utility of the social vulnerability index to risk stratify atrial fibrillation mortality outcomes
by: Ramzi Ibrahim, et al.
Published: (2023-08-01)

Association Between the Frailty and New-Onset Atrial Fibrillation/Flutter Among Elderly Hypertensive Patients
by: Fei Hang, et al.
Published: (2022-05-01)

Metformin reduces new-onset atrial fibrillation risk rather than atrial fibrillation burden in type 2 diabetes patients: A case-control study
by: Chongxia Zhong, et al.
Published: (2024-05-01)

Effects of Electrical Remodeling on Atrial Fibrillation in Diabetes Mellitus
by: Ling-ling Qian, et al.
Published: (2023-01-01)

New-Onset Atrial Fibrillation in Critically Ill Patients
by: Stephanie Sibley, et al.
Published: (2015-01-01)

Model to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset Diabetes
by: Sung Bum Kim
Published: (2018-09-01)

Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study
by: Anne C. K. Larstorp, et al.
Published: (2019-09-01)